Furthermore, the altered gut microbiota in patients with IBD activates their cytotoxic function, which supports their pro-inflammatory action as indicated by the release of TNF-α, IL-15, and IFN-γ, and the upregulation of CD107a expression. The gene discussed is TNF; the disease is inflammatory bowel disease.